Concepedia

Yu-Jie Xu

YX

Statistics

Publications

6

Citations

453

H-Index

6

Active since

2021

Affiliations

State Key Laboratory of Oncology in South China(Current)

Sun Yat-sen University

Sun Yat-sen University Cancer Center

First People's Hospital of Foshan

Twelfth Guangzhou City People's Hospital

Yu-Jie Xu is an author at State Key Laboratory of Oncology in South China specializing in oncology, medicine, and cancer pharmacology.

Publications per year

2021–2022

6

Publications

6

Lenvatinib, toripalimab, plus hepatic arterial infusion chemotherapy <i>versus</i> lenvatinib alone for advanced hepatocellular carcinoma

Minke He, Run-Bin Liang, Yang Zhao et al. · Therapeutic Advances in Medical Oncology · 2021 · 214 citations · Full text

, , +16

Lenvatinib, toripalimab plus hepatic arterial infusion chemotherapy in patients with high-risk advanced hepatocellular carcinoma: A biomolecular exploratory, phase II trial

ZhiCheng Lai, Minke He, Xiaoyun Bu et al. · European Journal of Cancer · 2022 · 150 citations

, , +16

Toripalimab Combined With Hepatic Arterial Infusion Chemotherapy Versus Lenvatinib for Advanced Hepatocellular Carcinoma

Yu-Jie Xu, ZhiCheng Lai, Minke He et al. · Technology in Cancer Research & Treatment · 2021 · 34 citations · Full text

, , +16

Regorafenib combined with programmed cell death-1 inhibitor against refractory colorectal cancer and the platelet-to-lymphocyte ratio’s prediction on effectiveness

Yu-Jie Xu, Peng Zhang, Jinlong Hu et al. · World Journal of Gastrointestinal Oncology · 2022 · 23 citations · Full text

, , +17

A novel qualitative signature based on lncRNA pairs for prognosis prediction in hepatocellular carcinoma

Xiaoyun Bu, Luyao Ma, Shuang Liu et al. · Cancer Cell International · 2022 · 18 citations · Full text

, , +17

1–5 of 6